Project Grant R01EB039412
- Federal Grant Award Summary Mayo Clinic received a $625,527 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), effective April 1, 2026 through March 31, 2030. The research initiative addresses critical limitations in cardiac computed tomography (CT) imaging for coronary artery disease assessment by developing solutions to overcome...
- Federal Grant Award Summary Mayo Clinic received a $1,276,961 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), effective August 1, 2025, with completion targeted for May 31, 2029. The award funds development of a dynamic, vendor-neutral patient projection data library and virtual imaging trial (VIT) platform designated...
- Federal Grant Award Summary Mayo Clinic received an $887.7K Project Grant award dated August 13, 2025, from the National Institute of Biomedical Imaging and Bioengineering under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The grant supports research and development of g-quadruplex-based supramolecular assemblies designed to function as activatable contrast agents for fluorescence imaging of estrogen receptor (ER) expression in...
- Federal Project Grant Award Summary Mayo Clinic received a $711,342 Project Grant award effective July 1, 2025, through June 30, 2030, from the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173). The award funds development of high-resolution clinical imaging techniques for inner ear diagnostics using photon-counting detector computed tomography (PCD-CT) and artificial intelligence (AI)...
- Federal Project Grant Award Summary Award Overview Mayo Clinic received a $722,914 Project Grant from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) effective June 1, 2026, through May 31, 2031. The grant funds research to develop and validate radiomic phenotypes—quantitative imaging features extracted from digital breast tomosynthesis (DBT) screening exams—to predict risk of invasive and advanced breast cancer across representative...
- Federal Project Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded The Johns Hopkins University a Project Grant valued at $507,987 on April 23, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The research, with performance through January 31, 2030, focuses on developing scintillator-based photon counting detectors (PCDs) for X-ray computed tomography (CT) systems. This...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded Mayo Clinic a $756,906 project grant (CFDA 93.837 – Cardiovascular Diseases Research) commencing September 1, 2025, and concluding June 30, 2029, to conduct a population-based study of deep learning measures of breast arterial calcification (BAC) for improving women's cardiovascular health using repurposed mammogram images. The research leverages automated artificial intelligence algorithms to...
- Federal Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded Lawrence Berkeley National Laboratory $312,165 on June 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop Time-of-Flight Multi-Photon Emission Tomography (TOF-MPET), a novel nuclear imaging modality designed to address critical limitations in imaging therapeutic radiopharmaceuticals (RPTs). The project,...
- Federal Grant Award Summary Mayo Clinic received a $643,606 Project Grant award from the National Cancer Institute (NCI) under the Cancer Detection and Diagnosis Research program (CFDA 93.394), effective June 2, 2026, through May 31, 2031. The award supports development of an artificial intelligence-powered diagnostic tool combining novel ultrasound technology with machine learning algorithms to improve early detection of choroidal melanoma, the most common primary intraocular malignancy in...
- Federal Grant Award Summary Mayo Clinic received a $667,710 Project Grant award from the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395) on March 20, 2026, for a project titled "Blood-Based Tumor and Immune Markers for Risk Stratification and Monitoring Treatment Response in Oligometastatic Prostate Cancer." The award extends through February 28, 2031, and will be performed at Mayo Clinic's facility in Rochester, Minnesota. The project delivers...
Mayo Clinic has been awarded $620,179 under the National Institute of Biomedical Imaging and Bioengineering (NIBIB) Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) for the period July 1, 2026 through May 31, 2030. The award funds the development and implementation of charge-sharing correction technology for photon-counting-detector (PCD) computed tomography (CT) systems, conducted in collaboration with Siemens Healthineers. The project will focus on advancing multi-energy CT (MECT) capabilities through coincidence-counting-based correction techniques to improve spectral separation and enable more accurate vascular plaque characterization in clinical applications. The deliverables include the installation, optimization, and validation of next-generation PCD-CT equipment equipped with charge-sharing correction capabilities, with evaluation conducted in both phantom studies and human subjects. The technology development will enhance quantitative assessment of plaque composition and soft plaque characteristics, addressing a clinical imaging gap in vascular disease assessment. Broader project outcomes will benefit all MECT applications by improving diagnostic capabilities and enabling new clinical applications beyond vascular imaging. The research will be performed at Mayo Clinic's Rochester, Minnesota facility.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $620.2k | 6/30/26 |